Posted on 5/1/17
Teva Pharmaceutical Is Looking to Deal, and That's a Good Thing
The tables have turned pretty quickly for Israeli-based branded- and generic-drug developer Teva Pharmaceutical Industries (NYSE:TEVA). In July 2015, shares of the company were trading north . . .
Posted on 5/1/17
3 Key Things to Watch in Pfizer's Q1 Results
When Pfizer (NYSE:PFE) reported its fourth-quarter 2016 performance in January, the results weren't all that great. The big drugmaker posted earnings per share that came in . . .
Posted on 5/1/17
J&J Snack Foods: Index Funds Appear To Be Creating Overvaluation
Back in December, I posted the following chart after J&J Snack Foods (NASDAQ:JJSF) released its Q4 report:Source: author from JJSF filings; EBITDA not adjusted, may differ . . .
Posted on 5/1/17
Johnson & Johnson (JNJ) Investor Presentation - Slideshow
The following slide deck was published by Johnson & Johnson in conjunction with this event. 125READ FULL ARTICLE HERE
Posted on 5/1/17
Merck's Daring Bid For Lung Cancer Domination
Not long ago Merck & Co. (NYSE:MRK) threw down the gauntlet to its oncology rivals, saying the checkpoint inhibitor space was all about winning in first-line . . .
Posted on 5/1/17
Celgene Corporation Earnings: Trading Price for Volume
Celgene (NASDAQ:CELG) reported strong first-quarter results on Thursday but with one minor issue.Celgene results: The raw numbersMetricQ1 2017Q1 2016Year-Over-Year ChangeRevenue$2.96 billion$2.51 billion17.8%Income from operations$1.11 billion$1.00 billion10.9%Earnings . . .
Posted on 5/1/17
3 Top Biotech Stocks to Buy Now
If you had invested $10,000 in three select biotech stocks three years ago, you'd now have nearly $98,000. Which three biotech stocks would have made this . . .
Posted on 5/1/17
The 3 Best Pharmaceutical Stocks to Buy in 2017
One big benefit that comes from owning pharmaceutical stocks is that their products remain in demand even during periods of economic stress. That allows drugmakers to . . .
Posted on 4/28/17
Comcast (CMCSA) Q1 2017 Results - Earnings Call Transcript
Comcast Corp. (NASDAQ:CMCSA)Q1 2017 Earnings CallApril 27, 2017 8:30 am ETExecutivesJason S. Armstrong - Comcast Corp.Brian L. Roberts - Comcast Corp.Michael J. Cavanagh - Comcast Corp.David . . .
Posted on 4/28/17
Celgene (CELG) Q1 2017 Results - Earnings Call Transcript
Celgene Corp. (NASDAQ:CELG)Q1 2017 Earnings CallApril 27, 2017 9:00 am ETExecutivesPatrick E. Flanigan III - Celgene Corp.Mark J. Alles - Celgene Corp.Peter N. Kellogg - Celgene . . .
Posted on 4/28/17
GlaxoSmithKline Q1 2017: Mixed Signals For Investors
On Wednesday, GlaxoSmithKline (NYSE:GSK) reported better than expected Q1/2017 results but only thanks to some positive phasing effect for the Vaccines business.The stock closed down 2% . . .
Posted on 4/28/17
What's Happening With Johnson & Johnson's Pharmaceuticals Business?
Johnson & Johnson's (NYSE:JNJ) pharmaceuticals business in on pace to account for half of the company's sales, and it's a major source of the company's earnings. . . .
Posted on 4/28/17
Moberg Raises $3 Million
Moberg ICU Solutions (Ambler, PA) has received an initial $3 million investment from Micromed SAS a wholly owned
Posted on 4/28/17
Mid-Atlantic Dental Partners Closes on 8th Practice at One Year Mark
PHILADELPHIA--(BUSINESS WIRE)--Mid-Atlantic Dental Service Holdings LLC, operating as Mid-Atlantic Dental Partners, a dental support organization (DSO) dedicated to improving the delivery of dental services for dentists . . .
Posted on 4/27/17
LifeBridge Health Teams with Cognizant
Cognizant (NASDAQ: CTSH) today announced it is working with LifeBridge Health, a leading health system in Maryland, to further innovate on a new communications system serving . . .
Posted on 4/27/17
MTBC Announces Signing of Two Key Healthcare Groups
MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of mHealth and cloud-based clinical and practice management solutions, announced the signing of two new clients yesterday who . . .
Posted on 4/27/17
Celgene Is A Must-Own Stock
Celgene (NASDAQ:CELG) is an American pharmaceutical stock which, in my opinion, has the most potential to grow out of any other large pharmaceutical company in the . . .
Posted on 4/27/17
Johnson & Johnson's Medical Device Business: What Investors Need to Know
Johnson & Johnson's (NYSE:JNJ) medical device business includes products that address everything from heart disease to hip replacement, and it accounts for about one-third of the . . .
Posted on 4/27/17
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 21, 2017 it approved non-statutory stock options to purchase 266,400 shares of its common stock to . . .
Posted on 4/26/17
PNC Financial Services (PNC) Investor Presentation - Slideshow
The following slide deck was published by PNC Financial Services Group, Inc. in conjunction with this event. 111READ FULL ARTICLE HERE
Posted on 4/26/17
Teva Pharmaceutical: Negative In 2015, And Still Negative In 2017
IntroductionTwo years ago, I wrote an article about Teva (NYSE:TEVA). Back then, the price was around $55, and it rose all the way to $69 six . . .
Posted on 4/26/17
3 Reasons Pfizer Is a Better Dividend Stock Than Bristol-Myers Squibb
Big pharma stocks have been popular among investors seeking solid dividends for a long time. And for good reason: Large drugmakers historically have generated such tremendous . . .
Posted on 4/26/17
J&J Snack Foods Corp's (JJSF) CEO Gerald Shreiber on Q2 2017 Results - Earnings Call Transcript
J&J Snack Foods Corp (NASDAQ:JJSF)Q2 2017 Earnings Conference CallApril 25, 2017, 10:00 ETExecutivesGerald Shreiber - Founder, Chairman, CEO and PresidentDennis Moore - CFO, SVP, Treasurer, Secretary . . .
Posted on 4/26/17
Better Buy: Celgene Corporation vs. Merck & Co., Inc.
Two of the hottest cancer drugs around belong to Celgene Corporation (NASDAQ:CELG) and Merck & Co., Inc. (NYSE:MRK). Celgene claims blockbuster blood cancer drug Revlimid, while . . .
Posted on 4/26/17
Here's Why Risk-Averse Investors May Want to Think Twice About Buying Johnson & Johnson
In many ways, healthcare conglomerate Johnson & Johnson (NYSE:JNJ) represents everything a risk-averse investor would be looking for in an investment.Johnson & Johnson has been a . . .

